Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
about
Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysPersistent infection of macaques with simian-human immunodeficiency virusesSimian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys.Characterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virusProtection by live, attenuated simian immunodeficiency virus against heterologous challenge.Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque salivaMultispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeysDissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization.Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo.Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation.Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotypeIdentification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.Infectivity and neutralization of simian immunodeficiency virus with FLAG epitope insertion in gp120 variable loops.High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
P2860
Q28751926-FFAECEC7-3FEB-4A32-8BDC-FCB8344CA77CQ28775731-B11A14BD-D28A-4897-BC6E-F96BE1EE99FDQ32157141-422874F7-A15B-4DEA-8BB0-161F4BDD1664Q33558407-C79F897A-C507-4DD2-A552-5C6CB5B881BCQ33809225-6542245F-1427-477B-8C79-08F842FF1F50Q33820014-67E05796-922D-4ED0-99F0-78A546973572Q33984371-05D3C37C-2CCE-4947-9574-91C51409F8E4Q34213868-7CF1919D-6057-434E-AF3D-654AB5F35CD7Q34226966-7361086E-DAEC-48BE-83D1-47BA9DF1E645Q34433975-4A9894EC-76A1-4B9C-887F-2A956EC09AA8Q35542887-78A08DE2-38DE-42A9-9DEA-1AD1BF2F2B4EQ35877501-3AFD0A4E-B3BB-4FD8-B1ED-CA5D178C534DQ35955770-C2B2B0E5-BEFE-45EF-85BE-D5DA33957941Q35985519-60579E3C-914E-4108-B907-5B77A1299648Q36155555-F55DA756-EA43-43F3-965A-C38532D9E6EBQ36751578-65CC67C2-0BF7-4FBF-9E26-95DCFF3E85EFQ36898925-64B9AD66-6ECE-451A-858C-3025FFFCDF7BQ37538534-609E1984-C64A-43A7-A829-842532E5BB52Q37683178-596EB6D5-DB79-4827-80A7-0C6CF02C07D7Q38860309-66B9B2A4-D78D-4F90-B439-31C58A2517EFQ39595739-8893D960-F965-4EFD-AC23-F56A357DD247Q39615794-EFFA2265-8CBB-4D1E-A0D4-996E977E71D0Q40096483-684CC9C9-476D-4829-B6A4-3812C1A9A311Q47552258-C4385A12-B558-404E-8273-939883777A03
P2860
Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Effects of natural sequence va ...... odeficiency virus infectivity.
@ast
Effects of natural sequence va ...... odeficiency virus infectivity.
@en
type
label
Effects of natural sequence va ...... odeficiency virus infectivity.
@ast
Effects of natural sequence va ...... odeficiency virus infectivity.
@en
prefLabel
Effects of natural sequence va ...... odeficiency virus infectivity.
@ast
Effects of natural sequence va ...... odeficiency virus infectivity.
@en
P2093
P2860
P1433
P1476
Effects of natural sequence va ...... nodeficiency virus infectivity
@en
P2093
C Collignon
C Thiriart
R C Desrosiers
P2860
P304
P407
P577
1994-09-01T00:00:00Z